Primary Site >> Stomach Cancer
Gene >> ROS1
|
|
|
|
|
|
|---|---|---|---|---|---|
|
Ref: Persistence of gene expression changes in stomach mucosae induced by short-term N-methyl-N'-nitro-N-nitrosoguanidine treatment and their presence in stomach cancers. PMID: 15120970 |
Ref: Identification of ROS1 rearrangement in gastric adenocarcinoma. PMID: 23400546 Ref: Towards the goal of personalized medicine in gastric cancer--time to move beyond HER2 inhibition. Part I: Targeting receptor tyrosine kinase gene amplification. PMID: 23819947 Ref: Towards the goal of personalized medicine in gastric cancer--time to move beyond HER2 inhibition. Part II: Targeting gene mutations and gene amplifications and the angiogenesis pathway. PMID: 23911227 |
Ref: Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma. PMID: 24122810 |
Ref: Prospective comprehensive genomic profiling of advanced gastric carcinoma cases reveals frequent clinically relevant genomic alterations and new routes for targeted therapies. PMID: 25882375 |
Ref: MET overexpression and amplification define a distinct molecular subgroup for targeted therapies in gastric cancer. PMID: 26404902 |
Ref: ROS1-1. PMID: 28903995 |